Dow Up 0.11% Nasdaq Up 0.50%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
11.82 Up 0.16(1.37%) Aug 29, 4:00PM EDT
|After Hours : 11.82 Up 0.00 (0.01%) Aug 29, 4:45PM EDT
Prev Close:11.66
Open:11.65
Bid:11.80 x 200
Ask:12.25 x 27000
1y Target Est:15.27
Beta:1.75
Earnings Date:Oct 23 - Oct 27 (Est.)
Day's Range:11.56 - 11.91
52wk Range:10.28 - 18.34
Volume:468,396
Avg Vol (3m):822,718
Market Cap:1.02B
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IMGNUp 1.37%1.02B
PFEUp 0.03%186.36B
RHHBYDown 0.14%248.08B
SGENUp 1.01%5.43B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.72
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.72
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback